---

Deposited Paper DEP 01/834

I. The prediction of biological activity. Porton Down technical paper no 951. CBDE. 1966. II. The effects of small doses of TL 2636 on human subjects at rest and exercising in the laboratory and in the field. Applied Biology Committee/CBDE. 1968. III. An oripavine derivate (TL 2636) as a potential incapacitating agent. Porton technical paper no 835. Chemical Defence Experimental Establishment. 1963. IV. A neuropharmacological comparison in the cat of the catalepsy producing drugs TL 2833, morphine and bulbocapnine. Technical paper no 8. Chemical Defence Establishment. 1969. V. The preparation of tertiary alcohols of the 6:14 endoetheno tetrahydro oripavine series. Nancekuke report no 78. Chemical Defence Experimental Establishment. 1966. VI. The effects of small oral doses of an oripavine derivative on human subjects under both laboratory and field conditions. Technical paper no 68. Chemical Defence Establishment. 1972. VII. Some application of potentiometric titrations in non-aqeuous media. Nancekuke internal note no 9. CDEE. 1965. VIII. Analysis of tertiary alcohols of the 6:14 endetheno tetrahydro oripavine series. CDEE. 1966.